+1-947-333-4405
+1-947-333-4405Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Is Drug Resistance in First-Line Therapy against All Antiretroviral Agents Inevitable?
Drug resistance has been observed in regard to all anti-retroviral drugs that have been studied until now. The most recent drug to be approved for use in HIV therapy is dolutegravir, an HIV integrase inhibitor, that was approved for therapy by the Food and Drug Administration in the United States in 2013. Dolutegravir is the only HIV drug that has ... Read More»
Mark A Wainberg and Thibault Mesplède
Research Article: J Infect Dis Ther 2015, 3: 208
DOI: 10.4172/2332-0877.1000208
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 